Received Jun 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | GG39D | — |
Infanrix expired (less than 30 days) dose administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 20-month-old female patient who received DTPa (Infanrix) (batch number GG39D, expiry date 05-JUN-2025) for prophylaxis. On 12-JUN-2025, the patient received the 4th dose of Infanrix. On 12-JUN-2025, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: Infanrix expired (less than 30 days) dose administration). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-JUN-2025 A Licensed Practical Nurse wanted to know how to proceed after administering an expired dose of Infanrix on 12th June 2025 to a patient, which led to Expired vaccine used. It was intended to be the fourth dose in the immunization schedule.